Tonghua Dongbao Pharmaceutical Co., Ltd. (600867.SS)
CNY 7.23
(-3.73%)
CNY 7.23
(-3.73%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | -954.2 Million CNY | -21.49% |
| 2022 | -785.41 Million CNY | 8.93% |
| 2021 | -862.38 Million CNY | -45.99% |
| 2020 | -590.72 Million CNY | -143.08% |
| 2019 | -243.01 Million CNY | -358.48% |
| 2018 | 94.01 Million CNY | 128.39% |
| 2017 | -331.16 Million CNY | -230.19% |
| 2016 | 254.37 Million CNY | -72.07% |
| 2015 | 910.58 Million CNY | 124.21% |
| 2014 | 406.12 Million CNY | 25.62% |
| 2013 | 323.29 Million CNY | 67.38% |
| 2012 | 193.15 Million CNY | 766.77% |
| 2011 | -28.96 Million CNY | -110.82% |
| 2010 | 267.8 Million CNY | -39.87% |
| 2009 | 445.37 Million CNY | -22.22% |
| 2008 | 572.63 Million CNY | -2.05% |
| 2007 | 584.62 Million CNY | 14.0% |
| 2006 | 512.85 Million CNY | 43.37% |
| 2005 | 357.71 Million CNY | 0.28% |
| 2004 | 356.7 Million CNY | 21.09% |
| 2003 | 294.57 Million CNY | 775.1% |
| 2002 | 33.66 Million CNY | 1264.27% |
| 2001 | -2.89 Million CNY | 55.08% |
| 2000 | -6.43 Million CNY | -204.89% |
| 1999 | 6.13 Million CNY | 106.48% |
| 1998 | -94.64 Million CNY | 27.72% |
| 1997 | -130.94 Million CNY | -7572.51% |
| 1996 | 1.75 Million CNY | 105.07% |
| 1995 | -34.55 Million CNY | 0.0% |
| 1994 | - CNY | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q1 | -843.27 Million CNY | 11.63% |
| 2024 Q3 | 159.92 Million CNY | 235.07% |
| 2024 Q2 | -118.39 Million CNY | 85.96% |
| 2023 FY | -954.2 Million CNY | -21.49% |
| 2023 Q2 | -448.16 Million CNY | 47.78% |
| 2023 Q4 | -954.2 Million CNY | -86.25% |
| 2023 Q3 | -512.33 Million CNY | -14.32% |
| 2023 Q1 | -858.22 Million CNY | -9.27% |
| 2022 Q2 | -1.07 Billion CNY | -3.77% |
| 2022 FY | -785.41 Million CNY | 8.93% |
| 2022 Q4 | -785.41 Million CNY | 34.97% |
| 2022 Q1 | -1.03 Billion CNY | -20.25% |
| 2022 Q3 | -1.2 Billion CNY | -12.24% |
| 2021 FY | -862.38 Million CNY | -45.99% |
| 2021 Q1 | -593.57 Million CNY | -0.48% |
| 2021 Q2 | -412.17 Million CNY | 30.56% |
| 2021 Q4 | -862.38 Million CNY | -69.71% |
| 2021 Q3 | -508.14 Million CNY | -23.28% |
| 2020 FY | -590.72 Million CNY | -143.08% |
| 2020 Q3 | -264.67 Million CNY | -312.68% |
| 2020 Q1 | -308.3 Million CNY | -26.87% |
| 2020 Q2 | -64.13 Million CNY | 79.2% |
| 2020 Q4 | -590.72 Million CNY | -123.19% |
| 2019 FY | -243.01 Million CNY | -358.48% |
| 2019 Q4 | -243.01 Million CNY | -12.34% |
| 2019 Q1 | -67.85 Million CNY | -172.18% |
| 2019 Q2 | 107.4 Million CNY | 258.27% |
| 2019 Q3 | -216.31 Million CNY | -301.41% |
| 2018 Q2 | -10.12 Million CNY | 97.85% |
| 2018 Q1 | -471.23 Million CNY | -42.3% |
| 2018 Q4 | 94.01 Million CNY | 9303.44% |
| 2018 FY | 94.01 Million CNY | 128.39% |
| 2018 Q3 | 999.81 Thousand CNY | 109.88% |
| 2017 Q2 | 26.49 Million CNY | -52.6% |
| 2017 Q3 | -124.56 Million CNY | -570.18% |
| 2017 Q1 | 55.88 Million CNY | -78.03% |
| 2017 Q4 | -331.16 Million CNY | -165.86% |
| 2017 FY | -331.16 Million CNY | -230.19% |
| 2016 Q3 | 1.39 Million CNY | -99.87% |
| 2016 Q1 | 938.29 Million CNY | 3.04% |
| 2016 Q2 | 1.08 Billion CNY | 15.81% |
| 2016 Q4 | 254.37 Million CNY | 18188.94% |
| 2016 FY | 254.37 Million CNY | -72.07% |
| 2015 Q4 | 910.58 Million CNY | 34.35% |
| 2015 Q2 | 608.27 Million CNY | 63.44% |
| 2015 FY | 910.58 Million CNY | 124.21% |
| 2015 Q1 | 372.15 Million CNY | -8.36% |
| 2015 Q3 | 677.77 Million CNY | 11.43% |
| 2014 Q2 | 367.77 Million CNY | 53.73% |
| 2014 Q4 | 406.12 Million CNY | -4.24% |
| 2014 Q3 | 424.09 Million CNY | 15.31% |
| 2014 Q1 | 239.23 Million CNY | -26.0% |
| 2014 FY | 406.12 Million CNY | 25.62% |
| 2013 Q2 | 363.38 Million CNY | 53.2% |
| 2013 FY | 323.29 Million CNY | 67.38% |
| 2013 Q4 | 323.29 Million CNY | -3.75% |
| 2013 Q1 | 237.19 Million CNY | 22.8% |
| 2013 Q3 | 335.9 Million CNY | -7.56% |
| 2012 FY | 193.15 Million CNY | 766.77% |
| 2012 Q4 | 193.15 Million CNY | 47.51% |
| 2012 Q3 | 130.94 Million CNY | -5.92% |
| 2012 Q2 | 139.17 Million CNY | 7057.87% |
| 2012 Q1 | -2 Million CNY | 93.1% |
| 2011 FY | -28.96 Million CNY | -110.82% |
| 2011 Q2 | 207.68 Million CNY | -25.86% |
| 2011 Q3 | -116.19 Million CNY | -155.95% |
| 2011 Q4 | -28.96 Million CNY | 75.07% |
| 2011 Q1 | 280.1 Million CNY | 4.6% |
| 2010 FY | 267.8 Million CNY | -39.87% |
| 2010 Q1 | 442.17 Million CNY | -0.72% |
| 2010 Q2 | 393.94 Million CNY | -10.91% |
| 2010 Q3 | 340.97 Million CNY | -13.44% |
| 2010 Q4 | 267.8 Million CNY | -21.46% |
| 2009 Q4 | 445.37 Million CNY | -16.72% |
| 2009 Q3 | 534.77 Million CNY | -4.57% |
| 2009 Q1 | 576.55 Million CNY | 0.69% |
| 2009 Q2 | 560.38 Million CNY | -2.8% |
| 2009 FY | 445.37 Million CNY | -22.22% |
| 2008 FY | 572.63 Million CNY | -2.05% |
| 2008 Q1 | 582.2 Million CNY | -0.41% |
| 2008 Q2 | 583.27 Million CNY | 0.18% |
| 2008 Q3 | 581.68 Million CNY | -0.27% |
| 2008 Q4 | 572.63 Million CNY | -1.56% |
| 2007 Q4 | 584.62 Million CNY | 4.05% |
| 2007 Q2 | 514.67 Million CNY | -6.18% |
| 2007 FY | 584.62 Million CNY | 14.0% |
| 2007 Q1 | 548.6 Million CNY | 6.97% |
| 2007 Q3 | 561.85 Million CNY | 9.17% |
| 2006 Q3 | 463.38 Million CNY | 13.88% |
| 2006 Q4 | 512.85 Million CNY | 10.68% |
| 2006 Q1 | 395.23 Million CNY | 10.49% |
| 2006 Q2 | 406.91 Million CNY | 2.96% |
| 2006 FY | 512.85 Million CNY | 43.37% |
| 2005 Q4 | 357.71 Million CNY | -10.69% |
| 2005 Q3 | 400.54 Million CNY | -0.73% |
| 2005 Q2 | 403.49 Million CNY | 10.9% |
| 2005 Q1 | 363.82 Million CNY | 2.0% |
| 2005 FY | 357.71 Million CNY | 0.28% |
| 2004 Q2 | 366.65 Million CNY | 6.14% |
| 2004 Q3 | 367.25 Million CNY | 0.16% |
| 2004 Q4 | 356.7 Million CNY | -2.87% |
| 2004 FY | 356.7 Million CNY | 21.09% |
| 2004 Q1 | 345.42 Million CNY | 17.26% |
| 2003 Q2 | 118.98 Million CNY | 19.96% |
| 2003 Q4 | 294.57 Million CNY | 70.88% |
| 2003 Q3 | 172.38 Million CNY | 44.89% |
| 2003 FY | 294.57 Million CNY | 775.1% |
| 2003 Q1 | 99.18 Million CNY | 194.66% |
| 2002 Q4 | 33.66 Million CNY | -35.58% |
| 2002 Q1 | - CNY | 100.0% |
| 2002 FY | 33.66 Million CNY | 1264.27% |
| 2002 Q3 | 52.25 Million CNY | 1093.5% |
| 2002 Q2 | -5.25 Million CNY | 0.0% |
| 2001 FY | -2.89 Million CNY | 55.08% |
| 2001 Q4 | -2.89 Million CNY | 0.0% |
| 2001 Q2 | -804.58 Thousand CNY | 0.0% |
| 2000 Q2 | 29.22 Million CNY | 0.0% |
| 2000 Q4 | -6.43 Million CNY | 0.0% |
| 2000 FY | -6.43 Million CNY | -204.89% |
| 1999 Q2 | -130.45 Million CNY | 0.0% |
| 1999 FY | 6.13 Million CNY | 106.48% |
| 1999 Q4 | 6.13 Million CNY | 0.0% |
| 1998 Q2 | 28.03 Million CNY | 0.0% |
| 1998 FY | -94.64 Million CNY | 27.72% |
| 1998 Q4 | -94.64 Million CNY | 0.0% |
| 1997 FY | -130.94 Million CNY | -7572.51% |
| 1997 Q4 | -130.94 Million CNY | 0.0% |
| 1997 Q2 | - CNY | 0.0% |
| 1996 Q4 | 1.75 Million CNY | 0.0% |
| 1996 FY | 1.75 Million CNY | 105.07% |
| 1996 Q2 | - CNY | 0.0% |
| 1995 Q4 | -34.55 Million CNY | 0.0% |
| 1995 FY | -34.55 Million CNY | 0.0% |
| 1995 Q2 | - CNY | 0.0% |
| 1994 FY | - CNY | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| Jiangsu Hengrui Medicine Co., Ltd. | -20.67 Billion CNY | 95.384% |
| Zhangzhou Pientzehuang Pharmaceutical., Ltd | 248.15 Million CNY | 484.526% |
| Zhejiang CONBA Pharmaceutical Co.,Ltd. | -1.53 Billion CNY | 37.793% |
| Shanghai Shenqi Pharmaceutical Investment Management Co., Ltd. | -309.42 Million CNY | -208.378% |
| Aurora Optoelectronics Co.,Ltd. | -251.17 Million CNY | -279.903% |
| Hangzhou TianMuShan Pharmaceutical Enterprise Co.,Ltd | 16.8 Million CNY | 5778.491% |
| NanJing Pharmaceutical Company Limited | 9.24 Billion CNY | 110.321% |
| GuangYuYuan Chinese Herbal Medicine Co., Ltd. | 32.59 Million CNY | 3027.332% |